Detail of GM0126
Summary
The genetically modified enzybiotic, named B30-443-Lyso , constructed by Domains Assembly strategy, change or extend lytic spectrum.With B30-443-Lyso
Sequence Length: 689 AA.
Mass: 76592.1 Da.
Isoelectric Point: 6.89
Function: actively lyse S. aureus and the same streptococcal test species as the parent B30 endolysin
Construction
GM0126, constructed by Domains Assembly strategy. No schema construted on GM0126
Details:
GM0126[1-443]: derive from protein Q5MY96 sequence 1-443
Q5MY96, 443 AA., the Lysin PlyGBS from Streptococcus phage NCTC11261
Source: Streptococcus phage NCTC11261
152 - 339: IPR017853, the Glycoside hydrolase, superfamily
390 - 437: IPR003646, the SH3-like domain, bacterial-type
Biological Process: 0009253, the peptidoglycan catabolic process
Biological Process: 0016998, the cell wall macromolecule catabolic process
Molecular Function: 0003796, the lysozyme activity
Linking to UniprotKB
Linging to InterPro
Domains and repeats
1 - 131: IPR007921, the CHAP domain152 - 339: IPR017853, the Glycoside hydrolase, superfamily
390 - 437: IPR003646, the SH3-like domain, bacterial-type
GO term prediction
Biological Process: 0005975, the carbohydrate metabolic processBiological Process: 0009253, the peptidoglycan catabolic process
Biological Process: 0016998, the cell wall macromolecule catabolic process
Molecular Function: 0003796, the lysozyme activity
Linking to UniprotKB
Linging to InterPro
GM0126[444-689]: derive from protein P10547 sequence 248-493
P10547, 493 AA., the Lysostaphin EC=3.4.24.75 from Staphylococcus simulans
Annotation
1-443
444-689
1-443
: EAD, full length domain, derived from S. agalactiae bacteriophage endolysin B30;444-689
: EAD, full length domain, derived from lysostaphin;Domain and repeats:
1-443
: IPR007921,CHAP domain; 1-443
: IPR017853,Glycoside hydrolase, superfamily; 1-443
: IPR003646,SH3-like domain, bacterial-type; 474-563
: IPR003646,Peptidase M23?; 607-677
: IPR003646,SH3-like domain, bacterial-type; GO term prediction:
MATYQEYKSRSNGNAYDIDGSFGAQCWDGYADYCKYLGLPYANCTNTGYARDIWEQRHENGILNYFDEVEVMQAGDVAIFMVVDGVTPYSHVAIFDSDAGGGYGWFLGQNQGGANGAYNIVKIPYSATYPTAFRPKVFKNAVTVTGNIGLNKGDYFIDVSAYQQADLTTTCQQAGTTKTIIKVSESIAWLSDRHQQQANTSDPIGYYHFGRFGGDSALAQREADLFLSNLPSKKVSYLVIDYEDSASADKQANTNAVIAFMDKIASAGYKPIYYSYKPFTLNNIDYQKIIAKYPNSIWIAGYPDYEVRTEPLWEFFPSMDGVRWWQFTSVGVAGGLDKNIVLLADDSSKMDIPKVDKPQELTFYQKLATNTKLDNSNVPYYEATLSTDYYVESKPNASSADKEFIKAGTRVRVYEKVNGWSRINHPESAQWVEDSYLVNATDM-AATHEHSAQWLNNYKKGYGYGPYPLGINGGMHYGVDFFMNIGTPVKAISSGKIVEAGWSNYGGGNQIGLIENDGVHRQWYMHLSKYNVKVGDYVKAGQIIGWSGSTGYSTAPHLHFQRMVNQFSNSTAQDPMPFLKSAGYGKAGGTVTPTPNTGWKTNKYGTLYKSESASFTPNTDIITRTTGPFRSMPQSGVLKAGQTIHYDEVMKQDGHVWVGYTGNSGQRIYLPVRTWQKSTNTLGVLWGTIK